High thrombus burden despite thrombolytic therapy in ST-elevation myocardial infarction in a patient with COVID-19.
Rev Cardiovasc Med
; 21(2): 289-295, 2020 06 30.
Article
em En
| MEDLINE
| ID: mdl-32706216
ABSTRACT
Consideration of thrombolysis as first-line reperfusion therapy in patients with COVID-19 and STEMI is recommended by ACC/SCAI guidelines. We describe a patient with COVID-19, who presented with ST-elevation myocardial infarction and was treated with thrombolysis and anticoagulation. He was later found to have a significant persistent thrombus burden requiring thrombectomy and stent placement. Invasive hemodynamics on multiple high-dose pressers revealed a high cardiac output state with low systemic vascular resistance, consistent with distributive rather than cardiogenic shock. Our case illustrates that thrombolytic therapy alone may not be adequate in patients with STEMI and COVID-19, as well as the importance of early invasive hemodynamics in management of shock in patient with STEMI and COVID-19 infection.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Trombose Coronária
/
Terapia Trombolítica
/
Trombectomia
/
Infecções por Coronavirus
/
Infarto do Miocárdio com Supradesnível do Segmento ST
Tipo de estudo:
Guideline
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Rev Cardiovasc Med
Assunto da revista:
ANGIOLOGIA
/
CARDIOLOGIA
Ano de publicação:
2020
Tipo de documento:
Article
País de afiliação:
Estados Unidos